Notes / Company

Q-Line Biotech Ltd.

QLINE ISIN INE1G2W01011 Medical Equipment

Fundamentals

Market cap: ₹1,275 cr
P/E: 22.88×
ROE: 14.81%
Debt / equity: 0.88
52-week range: 431.00 — 600.00

Research on Tijori Finance

Company snapshot

Q-Line Biotech Ltd.

Pharmaceuticals

₹1,344 cr

P/E 24.12×

Latest quarter · Mar 2026

Sales₹198 cr

Net profit₹34 cr

Op. margin+31.4%

EPS₹21.14

Strength & growth

Debt / equity0.88×

Current ratio1.48×

The timeline — 1 note on Q-Line Biotech Ltd.

June 2026

23 Jun 26 · 5:39 PM IST Brief

Brief · Concalls · Small cap

Q-Line Biotech's reagent shift lifts gross margin 750 bps, targets 30-35% growth

FY26 gross margin hits 60.8% as manufactured reagents replace imports; FY27 guidance backed by 300-400 new analyzer installations and ₹10 cr CDMO target.

Verify on exchange NSE filings for QLINE Tijori Finance company page